Literature DB >> 31915252

The GATOR2-mTORC2 axis mediates Sestrin2-induced AKT Ser/Thr kinase activation.

Allison Ho Kowalsky1, Sim Namkoong2, Eric Mettetal1, Hwan-Woo Park3, Dubek Kazyken4, Diane C Fingar4, Jun Hee Lee5.   

Abstract

Sestrins represent a family of stress-inducible proteins that prevent the progression of many age- and obesity-associated disorders. Endogenous Sestrins maintain insulin-dependent AKT Ser/Thr kinase (AKT) activation during high-fat diet-induced obesity, and overexpressed Sestrins activate AKT in various cell types, including liver and skeletal muscle cells. Although Sestrin-mediated AKT activation improves metabolic parameters, the mechanistic details underlying such improvement remain elusive. Here, we investigated how Sestrin2, the Sestrin homolog highly expressed in liver, induces strong AKT activation. We found that two known targets of Sestrin2, mTOR complex (mTORC) 1 and AMP-activated protein kinase, are not required for Sestrin2-induced AKT activation. Rather, phosphoinositol 3-kinase and mTORC2, kinases upstream of AKT, were essential for Sestrin2-induced AKT activation. Among these kinases, mTORC2 catalytic activity was strongly up-regulated upon Sestrin2 overexpression in an in vitro kinase assay, indicating that mTORC2 may represent the major link between Sestrin2 and AKT. As reported previously, Sestrin2 interacted with mTORC2; however, we found here that this interaction occurs indirectly through GATOR2, a pentameric protein complex that directly interacts with Sestrin2. Deleting or silencing WDR24 (WD repeat domain 24), the GATOR2 component essential for the Sestrin2-GATOR2 interaction, or WDR59, the GATOR2 component essential for the GATOR2-mTORC2 interaction, completely ablated Sestrin2-induced AKT activation. We also noted that Sestrin2 also directly binds to the pleckstrin homology domain of AKT and induces AKT translocation to the plasma membrane. These results uncover a signaling mechanism whereby Sestrin2 activates AKT through GATOR2 and mTORC2.
© 2020 Kowalsky et al.

Entities:  

Keywords:  Akt PKB; insulin resistance; liver metabolism; mTOR complex (mTORC); signal transduction

Mesh:

Substances:

Year:  2020        PMID: 31915252      PMCID: PMC7029113          DOI: 10.1074/jbc.RA119.010857

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  An in vitro assay for the kinase activity of mTOR complex 2.

Authors:  Jingxiang Huang
Journal:  Methods Mol Biol       Date:  2012

Review 2.  Sestrins orchestrate cellular metabolism to attenuate aging.

Authors:  Jun Hee Lee; Andrei V Budanov; Michael Karin
Journal:  Cell Metab       Date:  2013-09-19       Impact factor: 27.287

3.  Sestrin2 protein positively regulates AKT enzyme signaling and survival in human squamous cell carcinoma and melanoma cells.

Authors:  Baozhong Zhao; Palak Shah; Andrei V Budanov; Lei Qiang; Mei Ming; Andrew Aplin; Diane M Sims; Yu-Ying He
Journal:  J Biol Chem       Date:  2014-11-06       Impact factor: 5.157

Review 4.  A complex interplay between Akt, TSC2 and the two mTOR complexes.

Authors:  Jingxiang Huang; Brendan D Manning
Journal:  Biochem Soc Trans       Date:  2009-02       Impact factor: 5.407

5.  Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement.

Authors:  Hiraku Ono; Hitoshi Shimano; Hideki Katagiri; Naoya Yahagi; Hideyuki Sakoda; Yukiko Onishi; Motonobu Anai; Takehide Ogihara; Midori Fujishiro; Amelia Y I Viana; Yasushi Fukushima; Miho Abe; Nobuhiro Shojima; Masatoshi Kikuchi; Nobuhiro Yamada; Yoshitomo Oka; Tomoichiro Asano
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

6.  A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1.

Authors:  Liron Bar-Peled; Lynne Chantranupong; Andrew D Cherniack; Walter W Chen; Kathleen A Ottina; Brian C Grabiner; Eric D Spear; Scott L Carter; Matthew Meyerson; David M Sabatini
Journal:  Science       Date:  2013-05-31       Impact factor: 47.728

7.  Sestrin2 modulates AMPK subunit expression and its response to ionizing radiation in breast cancer cells.

Authors:  Toran Sanli; Katja Linher-Melville; Theodoros Tsakiridis; Gurmit Singh
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

8.  Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers.

Authors:  Hwan-Woo Park; Haeli Park; Ian A Semple; Insook Jang; Seung-Hyun Ro; Myungjin Kim; Victor A Cazares; Edward L Stuenkel; Jung-Jae Kim; Jeong Sig Kim; Jun Hee Lee
Journal:  Nat Commun       Date:  2014-09-05       Impact factor: 14.919

9.  Maintenance of metabolic homeostasis by Sestrin2 and Sestrin3.

Authors:  Jun Hee Lee; Andrei V Budanov; Saswata Talukdar; Eek Joong Park; Hae Li Park; Hwan-Woo Park; Gautam Bandyopadhyay; Ning Li; Mariam Aghajan; Insook Jang; Amber M Wolfe; Guy A Perkins; Mark H Ellisman; Ethan Bier; Miriam Scadeng; Marc Foretz; Benoit Viollet; Jerrold Olefsky; Michael Karin
Journal:  Cell Metab       Date:  2012-09-05       Impact factor: 27.287

10.  Sestrin 2 and AMPK connect hyperglycemia to Nox4-dependent endothelial nitric oxide synthase uncoupling and matrix protein expression.

Authors:  Assaad A Eid; Doug-Yoon Lee; Linda J Roman; Khaled Khazim; Yves Gorin
Journal:  Mol Cell Biol       Date:  2013-07-01       Impact factor: 4.272

View more
  11 in total

1.  Non-genomic activation of the AKT-mTOR pathway by the mitochondrial stress response in thyroid cancer.

Authors:  Woo Kyung Lee Doolittle; Sunmi Park; Seul Gi Lee; Seonhyang Jeong; Gibbeum Lee; Dongryeol Ryu; Kristina Schoonjans; Johan Auwerx; Jandee Lee; Young Suk Jo
Journal:  Oncogene       Date:  2022-10-04       Impact factor: 8.756

Review 2.  Regulation and metabolic functions of mTORC1 and mTORC2.

Authors:  Angelia Szwed; Eugene Kim; Estela Jacinto
Journal:  Physiol Rev       Date:  2021-02-18       Impact factor: 46.500

Review 3.  Protein Acetylation at the Interface of Genetics, Epigenetics and Environment in Cancer.

Authors:  Mio Harachi; Kenta Masui; Webster K Cavenee; Paul S Mischel; Noriyuki Shibata
Journal:  Metabolites       Date:  2021-04-01

Review 4.  SESTRINs: Emerging Dynamic Stress-Sensors in Metabolic and Environmental Health.

Authors:  Seung-Hyun Ro; Julianne Fay; Cesar I Cyuzuzo; Yura Jang; Naeun Lee; Hyun-Seob Song; Edward N Harris
Journal:  Front Cell Dev Biol       Date:  2020-12-03

5.  Association between serum Sestrin2 level and diabetic peripheral neuropathy in type 2 diabetic patients.

Authors:  En-Wen Mao; Xue-Bing Cheng; Wen-Chao Li; Cheng-Xia Kan; Na Huang; Hong-Sheng Wang; Ning-Ning Hou; Xiao-Dong Sun
Journal:  World J Clin Cases       Date:  2021-12-26       Impact factor: 1.337

Review 6.  SEA and GATOR 10 Years Later.

Authors:  Yahir A Loissell-Baltazar; Svetlana Dokudovskaya
Journal:  Cells       Date:  2021-10-08       Impact factor: 6.600

Review 7.  Sestrins in Physiological Stress Responses.

Authors:  Myungjin Kim; Allison H Kowalsky; Jun Hee Lee
Journal:  Annu Rev Physiol       Date:  2020-10-28       Impact factor: 19.318

Review 8.  Pathological Consequences of Hepatic mTORC1 Dysregulation.

Authors:  Chun-Seok Cho; Allison Ho Kowalsky; Jun Hee Lee
Journal:  Genes (Basel)       Date:  2020-08-05       Impact factor: 4.096

9.  FUS contributes to mTOR-dependent inhibition of translation.

Authors:  Myriam Sévigny; Isabelle Bourdeau Julien; Janani Priya Venkatasubramani; Jeremy B Hui; Paul A Dutchak; Chantelle F Sephton
Journal:  J Biol Chem       Date:  2020-10-20       Impact factor: 5.157

Review 10.  Sestrin2 in hypoxia and hypoxia-related diseases.

Authors:  Xiaojing Che; Jiagui Chai; Yan Fang; Xifeng Zhang; Anju Zu; Lin Li; Shibo Sun; Weimin Yang
Journal:  Redox Rep       Date:  2021-12       Impact factor: 4.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.